Amy Whitehead - Concepedia

Author

Amy Whitehead

University of Sheffield ORCID

Also Known As

A WHITEHEAD, A. Whitehead, Amy L Whitehead, Amy L. Whitehead, Amy Whitehead, Louise Stanton, Marian Reilly

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

University of Sheffield University of Southampton University Hospital Southampton NHS Foundation Trust Lancashire Teaching Hospitals NHS Foundation Trust Nottingham University Hospitals NHS Trust

About

Amy Whitehead is an author at University of Sheffield specializing in medicine, clinical trials, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	2K
2	Health Sciences	2	2	264
3	Engineering	1	1	1.7K
4	Biostatistics	1	1	1.7K
5	Emergency Medicine	1	1	14

Amy Whitehead

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable Amy Whitehead, Steven A. Julious, Cindy Cooper, Statistical Methods in Medical Research Sample Size JustificationMeta-analysisEngineeringContinuous Outcome VariableClinical Trials	2015	1.7K
An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database Sophie Billingham, Amy Whitehead, Steven A. Julious BMC Medical Research Methodology	2013	906
Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study M. Dawn Teare, Munyaradzi Dimairo, Neil Shephard, Trials	2014	748
The statistical interpretation of pilot trials: should significance thresholds be reconsidered? Ellen Lee, Amy Whitehead, Richard Jacques, BMC Medical Research Methodology	2014	421
Guidance for using pilot studies to inform the design of intervention trials with continuous outcomes Melanie L. Bell, Amy Whitehead, Steven A. Julious Clinical Epidemiology	2018	262
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial John Bridgewater, S. Pugh, Tom Maishman, The Lancet Oncology	2020	227
Pilot and feasibility studies: Is there a difference from each other and from a randomised controlled trial? Amy Whitehead, Benjamin Sully, Michael J. Campbell Contemporary Clinical Trials Health PolicyClinical EffectivenessClinical TrialsFeasibility StudiesRandomized Controlled Trial	2014	221
Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID) Simon J. Crabb, Gareth Griffiths, Ellice Marwood, Journal of Clinical Oncology	2020	77
Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial Simon J. Crabb, Gareth Griffiths, Denise Dunkley, European Urology UrologyHealth SciencesGenitourinary CancerMedicineCancer Management	2022	43
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE) Simon J. Crabb, Sarah Danson, James W.F. Catto, Clinical Cancer Research	2021	24

Page 1